141 results on '"Metafuni, E."'
Search Results
2. Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation
3. Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
4. P1353: EFFICACY OF SARSCOV2 VACCINATION IN PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION. A MULTICENTER EXPERIENCE
5. “A pilot study on the efficacy of Lactobacillus brevis CD2 lozenges in preventing oral mucositis by high-dose chemotherapy with autologous hematopoietic stem cell transplantation”: AB55
6. Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease
7. P21 - Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: SIMILAR MOLECULAR PATTERN IN T-AML IN PATIENTS TREATED WITH PARP INHIBITORS FOR METASTATIC OVARIAN CANCER
8. Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations
9. The role of HLA–G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis
10. CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE) AND THEIR IMPACT ON AUTOLOGOUS STEM CELL TRANSPLANTATION (AUTOSCT): A SINGLE CENTER EXPERIENCE: PH-AB063
11. Correlation between paraproteinaemia and viral reactivation after allo-SCT
12. Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia
13. Role of 18F-FDG PET-TC in evaluating response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukaemia: preliminary results in 9 cases: P1161
14. Hypoferritinemia prior to autologous stem cell transplantation: the role of underlying malignancy: P902
15. FECAL calprotectin as non-invasive biomarker of acute and chronic GvHD in allogeneic stem cell transplantation: P489
16. The Epstein-Barr virus-related post-transplant lymphoproliferative disorder treated with rituximab in a large cohort of children and adults: risk factor analysis of therapy response: 319
17. S1624 A DAY 100 LAB-SCORE PREDICTS EXTENSIVE CGVHD, OVERALL SURVIVAL AND TRANSPLANT-RELATED MORTALITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: FINAL ANALYSIS
18. The role of HLA–G 14bp polymorphism in allogeneic haematopoietic stem cell transplantation after short-term course methotrexate for graft-versus host disease prophylaxis
19. Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease
20. Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia
21. The role of HLA–G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis
22. The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue.
23. PREDICTING CHRONIC GRAFT VERSUS HOST DISEASE AND MORTALITY ON DAY+100 AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
24. Blinatumomab for the Treatment of Relapsed/refractory B-acute Lymphoblastic Leukemia: Report from a Single Center
25. Rate of re-admission in patients undergoing allogeneic transplants from identical siblings, unrelated donors or haploidentical donors
26. Comprehensive Geriatric Assessment, Allogeneic HSCT and Survival in AML Patients 65-75 Years Old
27. ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS OLDER THAN 60 YEARS: A REGISTRY STUDY OF THE TRANSPLANT ACTIVITY FROM 2000 TO 2017 ON BEHALF OF THE GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO (GITMO)
28. CD34 EXPRESSION CUT-OFF VALUE FOR PREDICTION OF PML-RAR alpha ISOFORMS IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA
29. Hypoferritinemia prior to autologous stem cell transplantation: the role of underlying malignancy
30. EFFICACY AND SAFETY PROFILE OF FOSCARNET AS PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPANT RECIPIENTS
31. CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE) AND THEIR IMPACT ON AUTOLOGOUS STEM CELL TRANSPLANTATION (AUTOSCT): A SINGLE CENTER EXPERIENCE
32. ACUTE GRAFT VERSUS HOST DISEASE: REDUCED INCIDENCE AND PREDICTIVE FACTORS
33. Triple PTCY Based GVHD Prophylaxis: HLA Matched Versus HLA Haploidentical Transplants
34. ROLE OF FLOW-CYTOMETRIC IMMUNOPHENOTYPING IN PREDICTION OF BCR/ABL GENE REARRANGEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
35. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
36. High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT.
37. Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.
38. MTHFR polymorphisms and vitamin B12 deficiency: correlation between mthfr polymorphisms and clinical and laboratory findings.
39. The impact of donor-specific antibodies' presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center.
40. Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.
41. Severe breakthrough hemolysis during compassionate use of Pegcetacoplan in paroxysmal nocturnal hemoglobinuria: managing an emergency.
42. Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review.
43. CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation.
44. Listeria monocytogenes Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Control Study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
45. Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era.
46. Hematopoietic stem cell transplantation: an Italian monocentric experience on the health assessment and eligibility of adult-related donors.
47. Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients.
48. Haploidentical bone marrow transplantation for AML in remission after TBF conditioning: a long-term follow-up.
49. Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity.
50. Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.